Abstract:Abstract Background This study aims to investigate thrombospondin 2 (TSP2) expression levels in gastric cancer (GC) and determine the relationship between TSP2 and clinical characteristics and prognosis. Methods The online database Gene Expression Profile Interactive Analysis (GEPIA) was used to analyse TSP2 mRNA expression levels in GC. The Kaplan–Meier plotter prognostic analysis tool was used to evaluate the influence of TSP2 expression on clinical prognosis in GC patients. TSP2 expression levels were analysed in paraffin-embedded GC samples and adjacent normal tissues by immunohistochemistry. The relationship between the clinicopathological characteristics and prognosis of GC patients was assessed. Transwell experiments were used to evaluate the effect of TSP2 on HGC27 and AGS cell invasion and migration. The EdU experiment was used to detect the effect of transfection of TSP2 on cell proliferation, and the flow cytometry experiment was used to detect the effect of TSP2 on cell apoptosis and the cell growth cycle. Western blotting (Wb) technology was used to detect MMP, E-cadherin, N-cadherin, Vimentin, Snail, AKT, PI3K, and VEGF protein expression in HGC27 cells. Results Compared with normal tissues, TSP2 mRNA expression in GC was significantly upregulated and was closely related to the clinical stage of GC. High TSP2 expression significantly affected the OS, FP and PPS of patients with GC. Among these patients, TSP2 expression levels did not affect the prognosis of patients with GC in the N0 subgroup but significantly affected the prognosis of patients with GC in the N (1 + 2 + 3) subgroup. TSP2 protein expression levels were significantly higher in GC tissue compared with normal tissues ( P < 0.01). The overall survival (OS) and relapse-free survival (RFS) of patients with high TSP2 expression were lower than those of patients with low TSP2 expression. Cells transfected with the TSP2-silencing sequence exhibited increased apoptosis and inhibition of proliferation, migration and invasion. AKT and PI3K expression in cells was significantly downregulated ( P < 0.01). AKT, PI3K and VEGF expression in cells transfected with the TSP2 silencing sequence was significantly reduced. Proliferation, migration, invasion ability, and TSP2 expression levels significantly correlated with mismatch repair genes, such as PMS2, MSH6, MSH2, and MLH1 ( P < 0.05). Conclusion TSP2 expression is significantly increased in GC. TSP2 expression is closely related to metastasis and the mismatch repair process in GC patients and affects GC patient prognosis. The mechanism may involve regulating gastric cancer cell proliferation and migration by modulating the VEGF/PI3K/AKT signalling pathway. TSP2 is a potential marker and therapeutic target for the prognosis of GC patients.

Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer

Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer.

Cystatin 2 leads to a worse prognosis in patients with gastric cancer

Comprehensive Analysis of the Biological Function and Immune Infiltration of SLC38A2 in Gastric Cancer.

CtBP2 Overexpression Promotes Tumor Cell Proliferation and Invasion in Gastric Cancer and is Associated with Poor Prognosis

Differential Expression of COL6 Family is a Potential Tumor Marker for Predicting Gastric Cancer

BST2 promotes gastric cancer metastasis under the regulation of HOXD9 and PABPC1

Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer

SCG2 is a Prognostic Biomarker Associated With Immune Infiltration and Macrophage Polarization in Colorectal Cancer

Overexpression of TC2N is Associated with Poor Prognosis in Gastric Cancer.

Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma.

Elevated THBS2, COL1A2, and SPP1 Expression Levels as Predictors of Gastric Cancer Prognosis.

Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target

BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer

Elevated Expression of ECT2 Predicts Unfavorable Prognosis in Patients with Colorectal Cancer.

Expression and Prognostic Significance of GATA-binding Protein 2 in Colorectal Cancer

BTG2 Suppresses the Growth and Metastasis of Cervical Squamous Cell Carcinoma

[TSR2 overexpression inhibits proliferation and invasion of gastric cancer cells by downregulating the PI3K/AKT signaling pathway]

Overexpression of UBE2C Correlates with Poor Prognosis in Gastric Cancer Patients.

Prognostic and Immunological Role of THBS2 in Colorectal Cancer.

The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer